Articles by Steven G. Reed

Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).
Oct 2, 2010
By: Christopher B. Fox, Timothy S. Dutill, James Chesko, Ryan C. Anderson, Steven G. Reed, Thomas S. Vedvick

Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).

Combating the devastating global disease of leishmaniasis with a new therapeutic and prophylactic vaccine
Jan 2, 2008
By: Thomas S. Vedvick, Lauren Carter, Garner Moulton, Yasuyuki Goto, Sylvie Bertholet, Steven G. Reed, Darrick Carter

The recombinant approach lends itself to the production of an inexpensive and effective vaccine at large scale.